WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014195880) AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/195880    International Application No.:    PCT/IB2014/061943
Publication Date: 11.12.2014 International Filing Date: 04.06.2014
Chapter 2 Demand Filed:    03.04.2015    
IPC:
A61K 39/02 (2006.01), C08B 37/00 (2006.01)
Applicants: WROCŁAWSKIE CENTRUM BADAŃ EIT+ SP. Z O.O. [PL/PL]; ul. Stabłowicka 147 PL-54-066 Wrocław (PL) (PL)
Inventors: GOŹDZIEWICZ, Tomasz; (PL).
ŁUKASIEWICZ, Jolanta; (PL).
ŁUGOWSKI, Czesław; (PL)
Agent: WITEK, Rafał; Wrocław 12 Rudolfa Weigla PL-53-114 Wrocław (PL)
Priority Data:
P.404229 06.06.2013 PL
Title (EN) AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
(FR) ANTIGÈNE BACTÉRIEN IMMUNOGÈNE ISOLÉ ET SON UTILISATION POUR LA PRÉVENTION ET LE TRAITEMENT D'INFECTIONS CAUSÉES PAR DES BACTÉRIES À GRAM NÉGATIF
Abstract: front page image
(EN)The subject of the present invention is an isolated antigen being an immunogenic form of the common enterobacterial antigen (ECA) of Gram-negative bacteria of the family Enterobacteriaceae: ECA combined with lipopolysaccharide (ECALPS); a glycoconjugate of inactivated form of this antigen with a protein, as well as compositions and vaccines containing such an antigen/glycoconjugate designed for the prevention and treatment infections caused by Gram-negative bacteria.
(FR)La présente invention concerne un antigène isolé qui est une forme immunogène du l'antigène entérobactérien commun (ECA) des bactéries à Gram négatif de la famille Enterobacteriaceae : ECA combiné avec un lipopolysaccharide (ECALPS) ; un glycoconjugué de forme inactivée de cet antigène avec une protéine, ainsi que des compositions et des vaccins contenant un tel antigène/glycoconjugué conçu pour la prévention et le traitement d'infections causées par des bactéries à Gram négatif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Polish (PL)